INS and type 1 diabetes mellitus: Data on T1DM, in particular, reflects a historical therapeutic environment (insulin was often only administered twice daily, glycaemic control was typically suboptimal, and rates of fetal and maternal complications were high [23]), limiting applicability to contemporary clinical populations.